Lab Tools

» biomarkers, mass spectrometry and cancer

Most Recent

image: Screening  with CRISPR

Screening with CRISPR

By | June 1, 2016

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

1 Comment

image: Pulling It All Together

Pulling It All Together

By | April 1, 2016

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

0 Comments

image: Cracking the Complex

Cracking the Complex

By | November 1, 2015

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

0 Comments

image: In Custody

In Custody

By | April 1, 2015

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

1 Comment

image: Tailoring Your Proteome View

Tailoring Your Proteome View

By | August 1, 2014

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

0 Comments

image: Bird’s-Eye Proteomics

Bird’s-Eye Proteomics

By | July 1, 2014

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

1 Comment

image: Moving Target

Moving Target

By | June 1, 2014

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

0 Comments

image: Capturing Cancer Cells on the Move

Capturing Cancer Cells on the Move

By | April 1, 2014

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

2 Comments

image: Name That Metabolite!

Name That Metabolite!

By | July 1, 2013

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

1 Comment

image: Suited to a T

Suited to a T

By | May 1, 2013

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech